category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-101,7.561948774000525e-11,1,15,46,photosynthesis light reactions,BioCyc
ARA:PHOTOALL-PWY,1.1114016493985549e-10,0.9999999999889131,19,85,oxygenic photosynthesis,BioCyc
ARA:PWY-6051,9.17911626077298e-5,0.9999974359243773,4,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:SULFMETII-PWY,1.36726472684964e-4,0.9999954309140674,4,9,sulfate reduction II (assimilatory),BioCyc
ARA:PWY-5064,9.578839884494862e-4,1,2,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5320,0.002248128030510946,0.9998046311766212,4,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-861,0.00254843630601867,0.9998803202598251,3,8,dhurrin biosynthesis,BioCyc
ARA:PWY-5194,0.0105269645376076,0.9996452602611543,2,5,siroheme biosynthesis,BioCyc
ARA:PWY-5068,0.010802597182413387,0.999599260306938,2,6,chlorophyll cycle,BioCyc
ARA:PWY-5321,0.024945020019924678,0.9940374590598944,5,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-6266,0.024945020019924678,0.9940374590598944,5,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,0.024945020019924678,0.9940374590598944,5,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-5079,0.02554095642778267,0.9983622131520222,2,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5086,0.026721673121025927,1,1,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5343,0.0275608168084509,1,1,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:CHLOROPHYLL-SYN,0.03258849543347766,0.9951274920568552,3,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:PWY-1422,0.03264746738873704,0.9975438006271407,2,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-5063,0.03541652912250235,1,1,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-6239,0.03605614081712878,1,1,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-5640,0.040571506298343524,1,1,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5070,0.04448990599777856,0.9960341570468033,2,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:CALVIN-PWY,0.04531093077419585,0.9893995204974712,4,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:PWY-5272,0.04573008393793528,0.9958611629453247,2,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-6890,0.05622680771884015,0.9991935786063109,1,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY4FS-12,0.05958384266828898,0.9990928041298259,1,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,0.05958384266828898,0.9990928041298259,1,2,extended VTC2 cycle,BioCyc
ARA:PWY-5271,0.06405017299626257,0.9989492224947949,1,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-7640,0.06405017299626257,0.9989492224947949,1,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-6932,0.06756220062761498,0.9988286487217718,1,2,selenate reduction,BioCyc
ARA:PWY-5036,0.07642799398537788,0.9984939548462802,1,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-6624,0.07818153654492016,0.9984225726462465,1,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6762,0.07818153654492016,0.9984225726462465,1,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-7468,0.07818153654492016,0.9984225726462465,1,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWYQT-62,0.08181263613282538,0.9817559272146408,3,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWY-1782,0.08594620738401179,0.9880259959022571,2,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-5035,0.09001069887341676,0.9872189705087056,2,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5486,0.09146552936704731,0.9867066823033717,2,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-5947,0.09886848682107324,0.9962067311193863,1,4,lutein biosynthesis,BioCyc
ARA:PWY-7436,0.10101444309191011,0.9964663414472289,1,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-5168,0.12173686970690879,0.9941886809166701,1,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY3DJ-35471,0.12507071099683753,0.9938565921230286,1,4,L-ascorbate biosynthesis IV,BioCyc
ARA:SUCSYN-PWY,0.12732801285172426,0.9653850888430182,3,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:PWY-6137,0.13534720729067592,0.992000414996313,1,6,copper transport II,BioCyc
ARA:PWY-5313,0.1473943641362301,0.9913786177394454,1,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-7267,0.1473943641362301,0.9913786177394454,1,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-6930,0.1484925078532027,0.9912451532378889,1,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6124,0.14933524290319,0.9902018833452526,1,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6842,0.15338403943972825,0.9371572836861839,5,71,glutathione-mediated detoxification II,BioCyc
ARA:PWY-3941,0.15738754263091215,0.9894950549236108,1,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-2181,0.16781983330190442,0.9879992819541481,1,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:PWY-5670,0.17002072818930988,0.986835988002708,1,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-5807,0.17641991236012447,0.9866852278978373,1,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-6014,0.17707998724216048,0.9865813181825751,1,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6710,0.17707998724216048,0.9865813181825751,1,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6364,0.22201870692746542,0.9755515820376408,1,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-5098,0.22540133033148987,0.9762840023576259,1,7,chlorophyll a degradation I,BioCyc
ARA:PWY-7450,0.23176332797023996,0.9389904130841494,2,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-2881,0.23466414357426096,0.9741851942642681,1,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,0.23466414357426096,0.9741851942642681,1,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-5791,0.2385549302436425,0.9723632894710023,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5837,0.2385549302436425,0.9723632894710023,1,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWYQT-4476,0.23915978258856613,0.9726152736037375,1,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWY-2261,0.2404419437840835,0.9350613094028807,2,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-3801,0.2468092867609138,0.9309914311704218,2,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-6348,0.25877952652441705,0.9265572074798095,2,27,phosphate acquisition,BioCyc
ARA:PWY-5125,0.2595526063709867,0.9674425218853977,1,8,anthocyanin biosynthesis,BioCyc
ARA:GLYSYN-PWY,0.26435018557661594,0.9649546093229302,1,11,glycine biosynthesis I,BioCyc
ARA:PWY-5267,0.26884516317687734,0.9644122328054513,1,9,glucosinolate activation,BioCyc
ARA:GLUCONEO-PWY,0.2692168095476009,0.8951038335643252,3,60,gluconeogenesis I,BioCyc
ARA:PWY-321,0.2739324481415962,0.9184408658218833,2,35,cutin biosynthesis,BioCyc
ARA:PWY-2021,0.27664476262866206,0.9617535789730569,1,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-5788,0.27664476262866206,0.9617535789730569,1,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-6219,0.27664476262866206,0.9617535789730569,1,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-6754,0.2841101764723769,0.9599733577582297,1,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6936,0.2913259275385998,0.957297389811316,1,10,seleno-amino acid biosynthesis,BioCyc
ARA:GLYSYN-ALA-PWY,0.2991581645806972,0.9540575141181187,1,12,glycine biosynthesis III,BioCyc
ARA:PWY-6733,0.30031624796510037,0.9046085503447175,2,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-5337,0.3013303496071842,0.9533411008919177,1,12,stachyose biosynthesis,BioCyc
ARA:PWY-5340,0.31349799245678994,0.9500312926460163,1,10,sulfate activation for sulfonation,BioCyc
ARA:PWY66-399,0.3138298236377974,0.8677805899296764,3,62,gluconeogenesis III,BioCyc
ARA:PWY-5136,0.32112039331634734,0.9459061414790364,1,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWYQT-4471,0.321570750257002,0.863247865707359,3,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWY-5484,0.3217817722341909,0.8626200046544321,3,63,glycolysis II (from fructose 6-phosphate),BioCyc
ARA:PENTOSE-P-PWY,0.3252435121329805,0.8912274821113186,2,36,pentose phosphate pathway,BioCyc
ARA:PWY-6724,0.33266963280437595,0.9413677352388545,1,15,starch degradation II,BioCyc
ARA:PWY-2161,0.34112958788486225,0.9378605767273965,1,16,folate polyglutamylation,BioCyc
ARA:HEME-BIOSYNTHESIS-II,0.34491053631367696,0.9368907550118275,1,14,heme biosynthesis I (aerobic),BioCyc
ARA:PWY-1081,0.3560810048129341,0.8729916613259221,2,38,homogalacturonan degradation,BioCyc
ARA:PWY-5859,0.35722225461130874,0.9331458383675935,1,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,0.35827721443691907,0.9311621729126749,1,15,methylerythritol phosphate pathway I,BioCyc
ARA:PWY-6927,0.3752546857353255,0.924193030406101,1,14,chlorophyll a degradation II,BioCyc
ARA:PWY-7560,0.3801077997828508,0.9211290654540598,1,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7186,0.3837358488005497,0.9200466330574953,1,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-6663,0.38639265533310235,0.9177909917838831,1,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-2541,0.38686392281396553,0.8530799240342617,2,44,plant sterol biosynthesis,BioCyc
ARA:PWY-6363,0.40681973926265586,0.9077323418106535,1,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:NONOXIPENT-PWY,0.41490656605165277,0.9047023308815496,1,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:PWY-5992,0.41490965471548136,0.83443505340015,2,42,thalianol and derivatives biosynthesis,BioCyc
ARA:GLYSYN2-PWY,0.42944986477359043,0.8960051228465198,1,20,glycine biosynthesis,BioCyc
ARA:PWY-3561,0.43141667232459674,0.8938911117182538,1,26,choline biosynthesis III,BioCyc
ARA:PWY-4101,0.4375422482971709,0.8924331268100271,1,17,D-sorbitol degradation I,BioCyc
ARA:PWY-7197,0.4471340310525338,0.8878762385294067,1,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:OXIDATIVEPENT-PWY,0.4776024384927743,0.868095765337673,1,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:PWY-1042,0.49809218013932355,0.7704914838661945,2,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-5386,0.5028675145131132,0.8511805705410889,1,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5884,0.5188516587762941,0.8401518900916776,1,22,wax esters biosynthesis I,BioCyc
ARA:PWY-882,0.527459825251334,0.833057035383931,1,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-5667,0.5424002636996555,0.8221727014280211,1,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,0.5592792881565399,0.8090616262295818,1,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:PWY-7211,0.5631191822971826,0.7131513070676183,2,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7187,0.5631280254512896,0.8065119175744986,1,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-621,0.5760203601101697,0.7945530779671484,1,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:CYSTSYN-PWY,0.580676357492466,0.7915172052477796,1,25,L-cysteine biosynthesis I,BioCyc
ARA:PWY-7176,0.59968385477288,0.7740856621773475,1,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY0-166,0.5997129408697364,0.774736351813607,1,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY-7416,0.6068989993936218,0.7680154309203088,1,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7200,0.6189160670925846,0.757144563206911,1,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-6545,0.633871072152061,0.74203114358691,1,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-581,0.6383002222029452,0.7372291828513693,1,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWY-6787,0.6412896671880937,0.7351534252911747,1,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-7528,0.6437418771647485,0.7324328186737621,1,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:LIPASYN-PWY,0.6446446202530038,0.6303068803352694,2,72,phospholipases,BioCyc
ARA:PWY4FS-8,0.6450334096220958,0.7302642739734518,1,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:ETHYL-PWY,0.6586500266163128,0.7163734897911559,1,31,ethylene biosynthesis I (plants),BioCyc
ARA:PWY0-162,0.665852814112655,0.7079537725423184,1,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-5980,0.6659904370975667,0.7081577053515813,1,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,0.6820812103942108,0.6904332312501924,1,33,flavonoid biosynthesis,BioCyc
ARA:PWY-181,0.684432207716597,0.6872386605912959,1,36,photorespiration,BioCyc
ARA:PWY-5687,0.6896108177212145,0.6810021128395681,1,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-7184,0.6896323594744438,0.6814625803854213,1,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-3841,0.6897172523545477,0.6808794123793435,1,38,folate transformations II,BioCyc
ARA:PWY-7208,0.690899704455584,0.6792302516450838,1,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-5121,0.6933867459269341,0.6772987653118591,1,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5723,0.7363319040961869,0.6229566309167723,1,41,Rubisco shunt,BioCyc
ARA:PWY-7039,0.7395367446742478,0.6174834170915444,1,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7196,0.7501504535824104,0.6036127152504998,1,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWYQT-4466,0.7634559065797603,0.5842823257246794,1,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWY-7270,0.7651174980450768,0.5833642076180885,1,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-7219,0.7896592418955617,0.5466427374684643,1,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-361,0.8449389058013225,0.45147779069280103,1,54,phenylpropanoid biosynthesis,BioCyc
ARA:TRIGLSYN-PWY,0.8620957462689645,0.4176284896373572,1,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:PWY-6803,0.8746438309200171,0.39223697064405727,1,65,phosphatidylcholine acyl editing,BioCyc
ARA:LIPAS-PWY,0.9477274461687059,0.21102333258263242,1,93,triacylglycerol degradation,BioCyc
ARA:PWY-4302,0.9611706148564572,0.1692450985043842,1,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:ALACAT2-PWY,1,0.7011588840937892,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.8053821030233292,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.8053821030233292,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.8685067334301557,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9216363763401946,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.9145816772064723,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.8351919572394123,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.6706495097522114,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.5955930548256015,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.616801515676227,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.8649557778439011,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.7975897130333339,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.8649557778439011,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.6846925305956578,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.6846925305956578,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.471650836228839,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.7104750472038308,0,10,cyanide detoxification I,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,1,0.3516289623295878,0,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.6479037019764358,0,12,spermidine biosynthesis I,BioCyc
ARA:CAMALEXIN-SYN,1,0.34944858689698755,0,29,camalexin biosynthesis,BioCyc
ARA:CITRULBIO-PWY,1,0.4000608487796574,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9635274503725642,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.7039109151919818,0,9,coenzyme A biosynthesis I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1,0.2810191525947809,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:CYANCAT-PWY,1,0.8885444999195306,0,3,cyanate degradation,BioCyc
ARA:DETOX1-PWY,1,0.5066353628641281,0,21,superoxide radicals degradation,BioCyc
ARA:DETOX1-PWY-1,1,0.37921605676499737,0,28,reactive oxygen species degradation,BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.6800409583998461,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.586802563905643,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.7310903583460178,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.6221069366079638,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9629015642342926,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.9303549502720644,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.8708151909545001,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.8708151909545001,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.49288853601160876,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9370595629841906,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.6914624703562292,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.8443080647961659,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.5899827942678675,0,17,glycine cleavage,BioCyc
ARA:GLYCOLYSIS,1,0.17004327861125773,0,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:GLYOXDEG-PWY,1,0.9548128359458778,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYOXYLATE-BYPASS,1,0.6203422418674277,0,17,glyoxylate cycle,BioCyc
ARA:HEXPPSYN-PWY,1,0.9332498454182013,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.5975196637440889,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9661347571396037,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.8513994939025863,0,4,L-threonine biosynthesis,BioCyc
ARA:HOMOSERSYN-PWY,1,0.8124185892656008,0,10,L-homoserine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.6235233512062471,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,1,0.5364474901851845,0,20,L-isoleucine degradation I,BioCyc
ARA:ILEUSYN-PWY,1,0.7266865321699838,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.9388429573936568,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9619942783005083,0,1,L-cysteine degradation II,BioCyc
ARA:LEU-DEG2-PWY,1,0.3815210718008073,0,32,L-leucine degradation I,BioCyc
ARA:LEUSYN-PWY,1,0.44599126441481757,0,27,L-leucine biosynthesis,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.734311325817533,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.5346100686719952,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.8712755692340662,0,4,D-mannose degradation,BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.7170136777451537,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.6718116770001002,0,11,lipid IVA biosynthesis,BioCyc
ARA:P401-PWY,1,0.7326936022743447,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.8113820572264308,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.8434626516624021,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PLPSAL-PWY,1,0.8807398848429087,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.909337170416859,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9106240877084413,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.8963965695560873,0,4,L-proline degradation,BioCyc
ARA:PWY-1001,1,0.6667907406720798,0,20,cellulose biosynthesis,BioCyc
ARA:PWY-102,1,0.7388324814900666,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1061,1,0.4012104150615887,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-112,1,0.8911595497151961,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-1121,1,0.1910896546735855,0,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-116,1,0.8710842128962027,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.7910106158486707,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.3190973078398279,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.7607380824466301,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1581,1,0.8022553677245675,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.7557212328549422,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1801,1,0.9316269010811066,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-1822,1,0.772928635209231,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.9693188186194609,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9300197768051087,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2161B,1,0.8172855651800663,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.7532853451541841,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2301,1,0.8218341644476294,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.6920168783014201,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2582,1,0.8168295425665444,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.956688853105283,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.566082524087555,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.7447580743181529,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9463131894931089,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.7642922418259712,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2821,1,0.5024149634375725,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.823894332131951,0,7,cytokinins degradation,BioCyc
ARA:PWY-2902,1,0.7551617682352889,0,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-3001,1,0.3331748433106616,0,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-3041,1,0.8951685582810406,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.6540247826441078,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.9258117737532292,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-3221,1,0.9615146069943218,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.8782860479930823,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.30912295500664994,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.8874018483310805,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.6648277937558372,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.7354504628280334,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.6440175198225062,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.5759233459266107,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3742,1,0.38367213395097105,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3781,1,0.018191553555197082,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWY-381,1,0.674898270574229,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.782728452305185,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3881,1,0.7884970679377624,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3982,1,0.9088647009125944,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9402261664032411,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.9145816772064723,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.786746994866452,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.7168255764885126,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.5989539246794774,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4203,1,0.8925586230976783,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.5707822052052711,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9395843997663884,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.8265198566372322,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4321,1,0.7252392932397729,0,12,L-glutamate degradation IV,BioCyc
ARA:PWY-4341,1,0.9751265071214145,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.514202843017338,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.6710677980524687,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.7174698009364289,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.6113949984906296,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.6547651207188312,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.8764071843777281,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.6113949984906296,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.5656609592425507,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.7939619111296251,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.7959084823154515,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.8555021377188821,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.8300781259480903,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.8526272865623251,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9816601443457704,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.8909518528708907,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5041,1,0.6424772098793767,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.6212454583452849,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.5909701063179054,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5049,1,0.9599332820668022,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.8640026198937795,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5080,1,0.24074193354965956,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5083,1,0.07143061574050562,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5084,1,0.6550185404922424,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5097,1,0.587235637839766,0,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5107,1,0.9274977810717413,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.7928406879088502,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9411061352195376,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.28370486667095174,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9706529431064569,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.5604425112894009,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5122,1,0.5345871967936081,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5123,1,0.46776331152139494,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-5129,1,0.373770727686293,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5138,1,0.7082290022969151,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.8147971410184812,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.6705292993325033,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.43551559603294393,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.7426049590516995,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.6954969881426808,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5172,1,0.8060215766614833,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9711041870464487,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.9766345293449163,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.6589374080437476,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5203,1,0.7939183083333018,0,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5269,1,0.7964455424099466,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5285,1,0.927833667084782,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.963050499134855,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5326,1,0.9323175859785512,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5342,1,0.9801173854956505,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5350,1,0.7033376803957745,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.8147971410184812,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.906194120083733,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.23822241479470255,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5389,1,0.88403263452378,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.7094288194543831,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.7695128934244686,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.8676967831729329,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5453,1,0.5923147932908129,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.8998592379867558,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9224902880923184,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.959553084693342,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5530,1,0.8127367467303134,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.34091095991192255,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5659,1,0.589989725705284,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.7150142890868182,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5669,1,0.8934850374138417,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5686,1,0.8358874708670012,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5690,1,0.25902918605983927,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.891841313434838,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9450405575970999,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9470740899650019,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.8977550900959892,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9835274893163629,0,1,urea degradation II,BioCyc
ARA:PWY-5765,1,0.8759767645201058,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9332498454182013,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5800,1,0.6567656886324391,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9332498454182013,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-5868,1,0.3851190865606859,0,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-5871,1,0.8052928909232006,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.9350646724488767,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5886,1,0.8823764897096612,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.8899342639280026,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.749104064461853,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.6768829249966662,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5936,1,0.4130235294497022,0,26,xyloglucan biosynthesis,BioCyc
ARA:PWY-5943,1,0.9619387023451693,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9637221844390128,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.884669822704401,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9711041870464487,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5957,1,0.8787357851259118,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.7330680135117839,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.2702283783861775,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.4042695844256988,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5986,1,0.9262565627217085,0,2,ammonium transport,BioCyc
ARA:PWY-5989,1,0.28628063673960613,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5995,1,0.9070587529417201,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.916688176771633,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9555758610376656,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.9625851521200608,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.9834302540305997,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9702254450377331,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.32392295735491,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.8591794016925476,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6019,1,0.8729975895065618,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6039,1,0.46260751349217083,0,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-6040,1,0.6390483478301039,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6064,1,0.928495574297368,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.9474467883205219,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.8347617661478238,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.7799605193133228,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.7902015461317132,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.7902015461317132,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9680423667133362,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6147,1,0.7989803639380721,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.7524333746208915,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.8486032813902233,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9248625390979043,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.7443364154737163,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-6213,1,0.8936295440658177,0,6,cadmium transport I,BioCyc
ARA:PWY-622,1,0.5115031572307442,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.8675538827827408,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.960662056703866,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.8675538827827408,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.8590035946542282,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6287,1,0.8572313784472511,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.9194180670352807,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.7208060644283397,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6303,1,0.8511192841122993,0,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6304,1,0.8701989655902445,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.8809765452530355,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.7080480517879948,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.6800409583998461,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6351,1,0.24891288736773404,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.2568179947804627,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6367,1,0.6550644389734154,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.8381134939056967,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9599141485323389,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-641,1,0.8686186026584395,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9210817589944198,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.7262062870331971,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.8151766510905764,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6443,1,0.1373814715813487,0,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6444,1,0.6925124060728463,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.5730963508284556,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.7700171332661769,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.7787574628125286,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.9430451863133649,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.710309502163193,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.7781915521397659,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.7772079526016744,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.955288250942698,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.8850870848094031,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.7174525850205226,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.9430451863133649,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.8400769146646891,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.755860116710802,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6546,1,0.7110623360888678,0,9,brassinosteroids inactivation,BioCyc
ARA:PWY-6549,1,0.39251642887887983,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.6113949984906296,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.8878860932986481,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9130609084963546,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.5627894880825159,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9177185793155127,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.7781117684154346,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.6771390894306911,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.6561538472308399,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.6863890271103348,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.6709810047265264,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.7481035285556066,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.7955616065766834,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.9485269895025087,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.8887368036787645,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6666,1,0.9257981842257434,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.7390334913653236,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9768368246434522,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6730,1,0.8389875786098328,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6736,1,0.9027827023157478,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.7734758714902126,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6756,1,0.7943541193838409,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6773,1,0.7749473389998582,0,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY-6786,1,0.5599738891285071,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6792,1,0.6639461955058443,0,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6799,1,0.9449339426955663,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.939541116528637,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6804,1,0.8589035722899067,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9147887003163222,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.509661414643477,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.7432899330119583,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.6889757734717217,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6845,1,0.9092645502501434,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6898,1,0.7309183299260267,0,8,thiamine salvage III,BioCyc
ARA:PWY-6902,1,0.5368552654429579,0,15,chitin degradation II (Vibrio),BioCyc
ARA:PWY-6908,1,0.6514281892703299,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9607815498085208,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9687035875539519,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.8077576526939858,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6931,1,0.9857515394616112,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6938,1,0.9468100320215515,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.6611006767043555,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.5985760456891298,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.5763153552232851,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.7038948890411768,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.7128562245379805,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.6504135047971383,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.755860116710802,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9618358525870223,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.5981772429550475,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7036,1,0.3644414622408965,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7047,1,0.7814296266832855,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.8333526096035881,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.8171324638583528,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.87132367277275935,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.8514856732220655,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.8514856732220655,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9208482580220301,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.8971265270659401,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.804319389939321,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9128291776320463,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.9272473088774277,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.9290457353243095,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7177,1,0.6677167391991814,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.7737103023341249,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7185,1,0.49791998446664154,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7193,1,0.6723074424609086,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7199,1,0.6905827027172144,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7204,1,0.5844826275858962,0,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:PWY-7205,1,0.5551534291645845,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.7656856140292517,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7213,1,0.8063130684784793,0,7,wogonin metabolism,BioCyc
ARA:PWY-7221,1,0.5055501732116557,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.5876584850100027,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.6405815732886558,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.6405815732886558,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.41221067890581,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-724,1,0.31256057783956365,0,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-7250,1,0.9626144610837952,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7325,1,0.9646533685224761,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.7807768065022468,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.8306172519665328,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.8387185437326168,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.468064062070572,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.6094552353802595,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.39676247097120765,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7398,1,0.48648269807664907,0,19,coumarins biosynthesis (engineered),BioCyc
ARA:PWY-7432,1,0.6853578659858633,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7590,1,0.9070791069355012,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.7284097141475431,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.8651418850663984,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-782,1,0.7372162738290398,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9064172746313596,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.8517609009939475,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9520267180339808,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9622099112929753,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.9194180670352807,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.6405815732886558,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-922,1,0.5786261618255367,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9069760768422062,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.8168192464357642,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.7876149061757537,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1313,1,0.8113683133646332,0,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY0-1319,1,0.6725352557456603,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.8649557778439011,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.7338904412356672,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9248625390979043,0,2,D-serine degradation,BioCyc
ARA:PWY0-461,1,0.8286683619050629,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.7860188133093219,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.928606882523081,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.7688520636649818,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY0A-6303,1,0.6217997690908407,0,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY1F-353,1,0.9254962953586932,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.8979432708690891,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.859268319834161,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY3O-450,1,0.7174507450143407,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.8681857546815608,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9241585395269112,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9002672451299829,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-2,1,0.6676111190709118,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.7687042000959369,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.7687042000959369,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.5510936065584506,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.677416296118339,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.5755397915612267,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY66-21,1,0.41002148510497677,0,34,ethanol degradation II,BioCyc
ARA:PWY66-423,1,0.8378455940399825,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.7908815230671569,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.8903691614392995,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9213373834108366,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.8844505630227365,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.8527782528151603,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.8876096999724974,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.5593066192876974,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.5259943020513795,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4450,1,0.7678640119006671,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4470,1,0.921251261768399,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4472,1,0.4149199561030973,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.4149199561030973,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.4149199561030973,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4475,1,0.34257536611878753,0,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWYQT-4477,1,0.5483449440758807,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.2422700897046784,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.7401836846706248,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-94,1,0.5463574477845201,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.8106776585960974,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.5141015697278384,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.6481881981313615,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.7703566794485608,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.8196078789973571,0,6,L-serine biosynthesis,BioCyc
ARA:THIOREDOX-PWY,1,0.4492318272911807,0,19,thioredoxin pathway,BioCyc
ARA:THRESYN-PWY,1,0.47288984608570694,0,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:TRESYN-PWY,1,0.5051373174495714,0,28,trehalose biosynthesis I,BioCyc
ARA:TRPSYN-PWY,1,0.4895989116918476,0,22,L-tryptophan biosynthesis,BioCyc
ARA:TYRFUMCAT-PWY,1,0.6143325790951915,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.7908139141148502,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALDEG-PWY,1,0.40946058469500746,0,30,L-valine degradation I,BioCyc
ARA:VALSYN-PWY,1,0.6585517551131403,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9019584738608294,0,4,xylose degradation I,BioCyc
